SEC Form 4 · accession 0001159036-15-000071
HALOZYME THERAPEUTICS, INC. · HALO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth J Kelley
Director
Period of report
Jun 18, 2015
Accepted (ET)
Jun 22, 2015 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001159036
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 18, 2015 | S | 20,000 | $21.00 | D | 198,051 | D |
Table II — derivative securities
No Table II lines on this filing.